OCT 16, 2020 7:30 AM PDT

FDA Warns Against NSAIDs After Week 20 of Pregnancy

WRITTEN BY: Annie Lennon

The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 weeks into pregnancy. They say that usage of the drugs may cause a rare but serious kidney problem to the unborn child. While a well-known risk among certain medical specialties, the announcement comes as an effort to communicate more widely to other specialties and pregnant women. 

After around 20 weeks of gestation, unborn babies' kidneys produce most of the amniotic fluid they need- the protective cushion that helps their lungs, digestive system, and muscles develop. Kidney problems caused by the usage of NSAIDs can lead to lower levels of this fluid being produced, which can then lead to further health complications. 

The recommendations are the result of a review of medical literature, including case reports, randomized control studies, and observational studies. While most of the publications suggest that the condition, known as oligohydramnios, tends to occur in the third trimester, some reported an earlier onset from around 20 weeks of gestation. 

The review also stated that, in most cases, oligohydramnios was reversible within 72 hours to 6 days of discontinuing usage of the NSAID.

"It is important that women understand the benefits and risks of the medications they may take over the course of their pregnancy," says Patrizia Cavazzoni, MD, acting director of FDA's Center for Drug Evaluation and Research. "To this end, the agency is using its regulatory authority to inform women and their healthcare providers about the risks if NSAIDs are used after around 20 weeks of pregnancy and beyond."

The announcement comes after previous warnings against using NSAIDs, including ibuprofen and celecoxib, after week 30 of pregnancy due to heart-related risks. As such, manufacturers of NSAIDs will now be required to update their labeling. 

The FDA mentioned, however, that a low-dose (81mg) aspirin is excluded from the precaution. They also mentioned that if a healthcare provider believes that NSAIDs are necessary for women between week 20 and 30 of pregnancy, their usage should be limited to the lowest effective dose for the shortest duration possible. 

 

Sources: MedscapeFDA

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 31, 2020
Cancer
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
AUG 31, 2020
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
Chemoresistance is a serious problem for many cancer therapies. Solutions to this problem are harder to come by than the ...
AUG 29, 2020
Drug Discovery & Development
MDMA and LSD Combo to Enter Clinical Trials
AUG 29, 2020
MDMA and LSD Combo to Enter Clinical Trials
Scientists from the pharmaceutical company, MindMed, have announced the beginning of Phase 1 clinical trials to test Sch ...
SEP 05, 2020
Drug Discovery & Development
Treatment in Cat Coronavirus Could Be Effective for Humans
SEP 05, 2020
Treatment in Cat Coronavirus Could Be Effective for Humans
Scientists at the University of Alberta are planning to launch clinical trials of a drug used to cure coronavirus in cat ...
SEP 07, 2020
Drug Discovery & Development
Improving Antirejection Medications in Heart Transplant
SEP 07, 2020
Improving Antirejection Medications in Heart Transplant
Placing patients on anti-rejection drugs is reality for all heart transplant patients. As such, recent research at Johns ...
SEP 29, 2020
Cardiology
Improving Acute Myocardial Ischemia Treatment with Nitro Fatty Acids
SEP 29, 2020
Improving Acute Myocardial Ischemia Treatment with Nitro Fatty Acids
Acute myocardial ischemia occurs when blood flow is restricted in the heart. This usually leads to cardiovascular issues ...
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
Loading Comments...